INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
INTENSITY THERAPEUTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.29−0.06 (-1.79%)
Close on Oct 19, 2026
- Market cap
- $8.90M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
35.8%
1M of 3M shares
Institutional holders
17
4 new, 1 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| LFP Management, LLC | 745,872 | 5.40% | 13G (passive) | May 31, 2024 |
| Lewis H. Bender | 2,245,000 | 16.10% | 13G (passive) | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of INTS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 496,493 | 15.21% | $2.04M | +458,439 | 1.72% |
| Kmt Wealth Management, LLC | 496,493 | 15.21% | $2.04M | New | 1.72% |
| Sentinus, LLC | 26,723 | 0.82% | $109.56K | +3,429 | 0.01% |
| Vanguard Capital Management LLC | 26,569 | 0.81% | $108.93K | +9,728 | 0.00% |
| Sapient Capital LLC | 26,006 | 0.80% | $106.63K | – | 0.00% |
| Nano Cap New Millennium Growth Fund L P | 25,000 | 0.77% | $102.50K | – | 0.08% |
| Geode Capital Management, LLC | 22,787 | 0.70% | $93.43K | −3,232 | 0.00% |
| FNY Investment Advisers, LLC | 22,000 | 0.67% | $90 | New | 0.03% |
| Mesirow Financial Investment Management, Inc. | 14,118 | 0.43% | $57.88K | – | 0.00% |
| Vanguard Fiduciary Trust Co | 9,121 | 0.28% | $37.40K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 1,984 | 0.06% | $8.13K | +1,917 | 0.00% |
| NewEdge Advisors, LLC | 1,148 | 0.04% | $4.71K | – | 0.00% |
| Osaic Holdings, Inc. | 200 | 0.01% | $820 | – | 0.00% |
| Barclays PLC | 42 | 0.00% | $172 | New | 0.00% |
| Morgan Stanley | 20 | 0.00% | $82 | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 6 | 0.00% | $25 | New | 0.00% |
| UBS Group AG | 1 | 0.00% | $4 | −191 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 1M | 35.8% | 4 / 4 | 2 / 1 | 1M | 0M |
| Q1 2026 | 14 | 0M | 5.5% | 14 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of INTS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 26,569 | 0.81% | $108.93K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 13,588 | 0.42% | $59.65K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 3,245 | 0.10% | $14.25K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 3,092 | 0.09% | $13.57K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 276 | 0.01% | $1.21K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Lewis H. Bender | President and CEO, Director | 118,549 | 3.63% | Jul 20, 2026 |
| Joseph Talamo | Chief Financial Officer | 2,239 | 0.07% | Jul 20, 2026 |
| John M. Wesolowski | Principal Accounting Officer | 7,102 | 0.22% | Jul 20, 2026 |
| Thomas I. H. Dubin | Director | – | – | Jul 20, 2026 |
| Mark A. Goldberg | Director | – | – | Jul 20, 2026 |
| Daniel Donovan | Director | – | – | Jul 20, 2026 |
| Emer Leahy | Director | – | – | Jul 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John M. Wesolowski Principal Accounting Officer | Jun 30, 2026 | Award | +3,688 | $3.49 | $12.87K | 7,102 |
| Joseph Talamo Chief Financial Officer | Jun 30, 2026 | Award | +1,093 | $3.49 | $3.81K | 2,239 |
| Lewis H. Bender President and CEO, Director | Mar 26, 2026 | Award | +37,749 | $6.11 | $230.65K | 118,549 |
| Joseph Talamo Chief Financial Officer | Dec 31, 2025 | Award | +14,482 | $0.26 | $3.77K | 28,661 |
| John M. Wesolowski Principal Accounting Officer | Dec 31, 2025 | Award | +8,918 | $0.26 | $2.32K | 85,354 |
| John M. Wesolowski Principal Accounting Officer | Jun 30, 2025 | Award | +69,745 | $0.26 | $18.13K | 76,436 |
| Joseph Talamo Chief Financial Officer | Jun 30, 2025 | Award | +14,179 | $0.26 | $3.69K | 14,179 |
| John M. Wesolowski Principal Accounting Officer | Jun 5, 2024 | Option exercise | +1,000 | $4.00 | $4.00K | 6,691 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.